RAB6B and hepatocellular carcinoma: While RAB6B has been linked to poor prognosis in breast cancer patients (van’t Veer et al. 2002), it is also a promising prognostic marker of hepatocellular carcinoma (Peng et al. 2022), and further in vitro studies are needed to explore its prognostic potential in renal metastasis as per our results.